Press Releases

“A Very Good Day”: The FDA Delivers on its Promise to Aid in the Fight Against Type 1 Diabetes

by Kimberly Ford Chisholm 12.02.2011 Lessons Earned
Thumbnail image for “A Very Good Day”: The FDA Delivers on its Promise to Aid in the Fight Against Type 1 Diabetes

FInd out why December 1 was a “very good day” for people with type 1 diabetes.

Read the full article →

JDRF and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes

by JDRF Bay Area 06.09.2011 Press Releases
Thumbnail image for JDRF and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes

Through the research partnership, JDRF will provide milestone-based financial support and expertise, with the goal of applying Selecta’s vaccine technology toward the development of vaccines for type 1 diabetes.

Read the full article →

Scientists Identify Key Trigger for Pancreatic Beta Cell Regeneration

by JDRF Bay Area 04.06.2011 Press Releases
Thumbnail image for Scientists Identify Key Trigger for Pancreatic Beta Cell Regeneration

JDRF-funded study reveals that a glucose-sensing enzyme signals the production of new insulin-producing cells, suggesting a new path of treatment possibilities for type 1 diabetes.

Read the full article →

Merck to Acquire SmartCells, A JDRF-funded Company

by JDRF Bay Area 12.03.2010 Press Releases
Thumbnail image for Merck to Acquire SmartCells, A JDRF-funded Company

JDRF provided financial support for SmartCells from 2008-2010 for proof-of-concept preclinical trials for its SmartInsulin™ product, which is designed to be a novel once-a-day injection that will maintain continuous, tight control of blood glucose levels while reducing the risk of hypoglycemia.

Read the full article →

JDRF Announces Partnership to Investigate a Potential Therapy to Improve Blood Glucose Control

by JDRF Bay Area 11.16.2010 Press Releases
Thumbnail image for JDRF Announces Partnership to Investigate a Potential Therapy to Improve Blood Glucose Control

JDRF and Amylin Pharmaceuticals partner to investigate Metreleptin as potential therapy to improve blood glucose control in type 1 diabetes. Clinical proof-of-concept study will also evaluate whether metreleptin can reduce the amount of insulin needed by patients with type 1 diabetes.

Read the full article →

JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

by JDRF Bay Area 11.12.2010 Advocacy
Thumbnail image for JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.

Read the full article →

JDRF Rallies for Continued Support of Diabetes Research during National Diabetes Awareness Month

by JDRF Bay Area 11.08.2010 Press Releases
Thumbnail image for JDRF Rallies for Continued Support of Diabetes Research during National Diabetes Awareness Month

November is National Diabetes Awareness Month, a time to bring attention to priority issues for those of us trying to bring about an end to type 1 diabetes.

Read the full article →

Opportunity to Join the JDRF Staff as a Development Director

by Greg Martin 07.14.2010 Press Releases

ShareWe have just realigned our staff, transitioning from an event-driven model to geographically-based teams.  In doing so we feel we are better prepared as partners to our volunteers; to meet the needs of the diabetes communities and communities in general; and to steward the donors within the Greater Bay Area.  This restructure creates an opportunity [...]

Read the full article →

← Previous Entries